West Announces Fourth-Quarter and Full-Year 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
West Pharma (WST) Tops Q4 EPS by 13c, Offers Guidance
February 17, 2022 6:08 AM ESTWest Pharma (NYSE: WST) reported Q4 EPS of $2.04, $0.13 better than the analyst estimate of $1.91. Revenue for the quarter came in at $730.8 million versus the consensus estimate of $710.2 million.
GUIDANCE:
West Pharma sees FY2022 EPS of $9.20-$9.35, versus the consensus of... More
